Current progress in immunotherapy of hepatocellular carcinoma

被引：44

作者：

Sprinzl, Martin F. ^{[1
]}

Galle, Peter R. ^{[1
]}

机构：

[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Langenbeckstr 1, D-55131 Mainz, Germany

来源：

关键词：

Liver cancer; Therapy; Immunotherapy; Checkpoint inhibitors; REGULATORY T-CELLS; THERMAL ABLATION; DOCETAXEL; BLOCKADE; NIVOLUMAB; PD-L1;

D O I：

10.1016/j.jhep.2016.12.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：482 / 484

页数：3

共 50 条

[31] Hepatocellular Carcinoma Immunotherapy
Sperandio, Rubens Copia
Pestana, Roberto Carmagnani
Miyamura, Beatriz Viesser
Kaseb, Ahmed O.
ANNUAL REVIEW OF MEDICINE, 2022, 73 : 267 - 278
[32] Immunotherapy of hepatocellular carcinoma
Geissler, M
Mohr, L
Blum, HE
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2001, 126 (51-52) : 1464 - 1466
[33] Immunotherapy for hepatocellular carcinoma
Yin Zongyi
Li Xiaowu
CANCER LETTERS, 2020, 470 : 8 - 17
[34] Immunotherapy in Hepatocellular Carcinoma
Claudia A. M. Fulgenzi
Thomas Talbot
Sam M. Murray
Marianna Silletta
Bruno Vincenzi
Alessio Cortellini
David J. Pinato
Current Treatment Options in Oncology, 2021, 22
[35] Immunotherapy in hepatocellular carcinoma
Jones, RL
Young, LS
Adams, DH
LANCET, 2000, 356 (9232): : 784 - 785
[36] Immunotherapy for hepatocellular carcinoma
Wang Xiaoxia
Lu Jun
中华医学杂志英文版, 2024, 137 (15)
[37] Immunotherapy of hepatocellular carcinoma
Butterfield, LH
Ribas, A
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (02) : 123 - 133
[38] Immunotherapy of hepatocellular carcinoma
Greten, Tim
Korangy, Firouzeh
INFLAMMATION RESEARCH, 2007, 56 : S146 - S147
[39] Immunotherapy of Hepatocellular Carcinoma
Heinrich, Bernd
Czauderna, Carolin
Marquardt, Jens U.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (05) : 292 - 297
[40] Immunotherapy of hepatocellular carcinoma
Greten, Tim F.
Manns, Michael P.
Korangy, Firouzeh
JOURNAL OF HEPATOLOGY, 2006, 45 (06) : 868 - 878